Uveitis clinical trials at UC Irvine
1 in progress, 0 open to eligible people
Showing trials for
Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis
Sorry, in progress, not accepting new patients
The purpose of this study is to determine the safety and efficacy of brepocitinib in participants with active, non-anterior (intermediate, posterior, or pan) non-infectious uveitis (NIU).
Irvine, California and other locations
Our lead scientists for Uveitis research studies include Sanjay Kedhar.
Last updated: